Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Peiris

Showing results (491-500 of 661) with videos related to

Pageof 67
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Temporally structured metapopulation dynamics and persistence of influenza A H3N2 virus in humansJustin Bahl, Martha I Nelson, Kwok H Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2014
Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009-2012Benjamin J Cowling, Ranawaka A P M Perera, Vicky J Fang, et al.
The Lancet. Microbe|April 22, 2023
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort studyChris Ka Pun Mok, Chunke Chen, Shilin Zhao, et al.
Nature Immunology|August 29, 2020
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infectionAsmaa Hachim, Niloufar Kavian, Carolyn A Cohen, et al.
Vaccine|December 28, 2005
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolateTaisuke Horimoto, Ayato Takada, Ken Fujii, et al.
The Journal of Infectious Diseases|December 8, 2025
Anti-neuraminidase antibody responses in older adults after consecutive vaccinations with enhanced influenza vaccines: a randomized controlled trialPavithra Daulagala, Yonna W Y Leung, Leo L H Luk, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2026
Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025Samuel Ms Cheng, Nancy Hl Leung, Eunice Y Shiu, et al.
Emerging Infectious Diseases|December 3, 2021
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021Haogao Gu, Pavithra Krishnan, Daisy Y M Ng, et al.
Emerging Infectious Diseases|September 25, 2015
Effect of Live Poultry Market Closure on Avian Influenza A(H7N9) Virus Activity in Guangzhou, China, 2014Jun Yuan, Eric H Y Lau, Kuibiao Li, et al.
Pageof 67

Showing results (491-500 of 661) with videos related to

Sort By:
Pageof 67
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2011
Temporally structured metapopulation dynamics and persistence of influenza A H3N2 virus in humansJustin Bahl, Martha I Nelson, Kwok H Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2014
Incidence of influenza virus infections in children in Hong Kong in a 3-year randomized placebo-controlled vaccine study, 2009-2012Benjamin J Cowling, Ranawaka A P M Perera, Vicky J Fang, et al.
The Lancet. Microbe|April 22, 2023
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort studyChris Ka Pun Mok, Chunke Chen, Shilin Zhao, et al.
Nature Immunology|August 29, 2020
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infectionAsmaa Hachim, Niloufar Kavian, Carolyn A Cohen, et al.
Vaccine|December 28, 2005
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolateTaisuke Horimoto, Ayato Takada, Ken Fujii, et al.
The Journal of Infectious Diseases|December 8, 2025
Anti-neuraminidase antibody responses in older adults after consecutive vaccinations with enhanced influenza vaccines: a randomized controlled trialPavithra Daulagala, Yonna W Y Leung, Leo L H Luk, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2026
Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025Samuel Ms Cheng, Nancy Hl Leung, Eunice Y Shiu, et al.
Emerging Infectious Diseases|December 3, 2021
Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021Haogao Gu, Pavithra Krishnan, Daisy Y M Ng, et al.
Emerging Infectious Diseases|September 25, 2015
Effect of Live Poultry Market Closure on Avian Influenza A(H7N9) Virus Activity in Guangzhou, China, 2014Jun Yuan, Eric H Y Lau, Kuibiao Li, et al.
Pageof 67